Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06721624 · ClinicalTrials.gov registry record
Prospective Observational Study of Naturopathic Approaches to IBS
A clinical trial of Irritable Bowel Syndrome (IBS), sponsored by National University of Natural Medicine.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06721624 is a study of Irritable Bowel Syndrome (IBS) that is actively recruiting participants, run by National University of Natural Medicine. The registered enrollment target is 50 participants, below the 1,179-participant average among 5 other Irritable Bowel Syndrome (IBS) trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06721624, a study of Irritable Bowel Syndrome (IBS), is actively recruiting participants, sponsored by National University of Natural Medicine.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Irritable bowel syndrome (IBS) is a common condition affecting about 4% of people worldwide and can significantly impact quality of life and healthcare costs. While there are medications available, few are consistently effective, leading many people with IBS to explore alternative treatments, including naturopathy. However, research on naturopathic approaches to IBS is limited. This study aims to describe how naturopathy is used to treat IBS and to collect preliminary data on changes in IBS symptoms before and after treatment. It will use a prospective, observational design without a control group, focusing on outcomes from individualized naturopathic care provided by licensed practitioners. Adult patients with diagnosed IBS or IBS-like symptoms will be recruited from naturopathic doctors affiliated with the Gastroenterology Association of Naturopathic Physicians. Participants' IBS symptoms will be assessed using validated tools (IBS-SSS and IBS-AR), and quality of life will be measured using the PROMIS-29 survey. Treatment details and any adverse effects will also be recorded. The main outcome will be the difference in symptoms and quality of life after 12 weeks of treatment. Results will be analyzed with statistical tests (p-value \< 0.05) and summarized. The findings from this pilot study will help fill knowledge gaps and provide a foundation for designing a more rigorous randomized controlled trial in the future.
Conditions Studied
Interventions
- OTHER Naturopathic medicine
Study Locations (1)
Oregon
- Helfgott Research Institute - National University of Natural Medicine - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-11-01 |
| Est. Completion | 2025-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06721624
The ClinicalTrials.gov registry entry for NCT06721624 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,179-participant average among 5 other Irritable Bowel Syndrome (IBS) trials with a reported enrollment target (96% lower). The listed sponsor is National University of Natural Medicine, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Irritable Bowel Syndrome (IBS) appearing as the primary indexed condition, and to 1 intervention - of which Naturopathic medicine is the first listed.
NCT06721624 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT06721624 about?
NCT06721624 is a clinical study titled "Prospective Observational Study of Naturopathic Approaches to IBS". Irritable bowel syndrome (IBS) is a common condition affecting about 4% of people worldwide and can significantly impact quality of life and healthcare costs. While there are medications available, few are consistently effective, leading many people with IBS to explore alternative treatments, includ...
What is the current status of trial NCT06721624?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2024-11-01. Estimated completion is 2025-11.
What conditions does trial NCT06721624 study?
This clinical trial studies the following conditions: Irritable Bowel Syndrome (IBS).
What interventions are being tested in trial NCT06721624?
The interventions under investigation include: Naturopathic medicine (OTHER).
Who is sponsoring clinical trial NCT06721624?
This trial is sponsored by National University of Natural Medicine, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06721624 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Irritable Bowel Syndrome (IBS)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
A Randomized Crossover Trial of Bright Light Therapy in Irritable Bowel Syndrome
RECRUITING · NA
-
Irritable Bowel Syndrome and Control Volunteers: Diet Challenge
RECRUITING · NA
-
Diet and Motility in IBS
RECRUITING
-
Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.